RAJAGOPAL SEKHAR to HIV Infections
This is a "connection" page, showing publications RAJAGOPAL SEKHAR has written about HIV Infections.
Connection Strength
1.410
-
Supplementing glycine and N-acetylcysteine (GlyNAC) rapidly improves health-related quality of life and lowers perception of fatigue in patients with HIV. AIDS. 2021 07 15; 35(9):1522-1524.
Score: 0.327
-
Increasing glutathione concentrations with cysteine and glycine supplementation lowers inflammation in HIV patients. AIDS. 2015 Sep 10; 29(14):1899-900.
Score: 0.218
-
Treatment of dyslipidemia in HIV. Curr Atheroscler Rep. 2015 Apr; 17(4):493.
Score: 0.212
-
Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients. J Clin Endocrinol Metab. 2014 Jan; 99(1):169-77.
Score: 0.194
-
Treatment of dyslipidemia in HIV-infected patients. Expert Opin Pharmacother. 2010 Aug; 11(11):1845-54.
Score: 0.153
-
HIV-associated lipodystrophy syndrome: an accelerated form of the metabolic syndrome of insulin resistance due to altered fat distribution. Res Initiat Treat Action. 2006; 12(1):5-11.
Score: 0.112
-
Metabolic basis of HIV-lipodystrophy syndrome. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E332-7.
Score: 0.088
-
Dysregulated energy expenditure in HIV-infected patients: a mechanistic review. Clin Infect Dis. 2007 Jun 01; 44(11):1509-17.
Score: 0.030
-
Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome. Am J Clin Nutr. 2005 Jun; 81(6):1405-10.
Score: 0.027
-
Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy. Curr Atheroscler Rep. 2004 May; 6(3):173-9.
Score: 0.025
-
Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'. Curr Opin Lipidol. 2004 Feb; 15(1):59-67.
Score: 0.024